Grozinsky-Glasberg, S., Rubinfeld, H., Gorshtein, A., Prais, M., Kendler, E., Feinmesser, R., Grossman, A., & Shimon, I. (2016). The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-mTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells. 90(1), 115–115.

Grozinsky-Glasberg, S., et al. The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-MTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells. no. 1, 2016, pp. 115–15.

Grozinsky-Glasberg, S, H Rubinfeld, A Gorshtein, M Prais, E Kendler, R Feinmesser, A Grossman, and I Shimon. 2016. “The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-MTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells.” In , 90:115–15.